|
founded EPISTAT, an international pharmaceutical and health care strategy company, and has served as its Chief Executive Officer since 1985. He has also served as Chief Executive Officer of MetaStat, an oncology drug development firm, since 1994. In addition, Dr. Keltner is Chairman of Light Sciences Corporation, a company developing light-activated drugs, and serves as CEO of Light Sciences Oncology, a company in late-stage development of cancer therapies. Dr. Keltner is currently on the board of directors of Infostat, Inc., a contract research organization; Oregon Life Sciences, a venture investment company focused on the bio-med and biotech sectors; LKHealthnet Inc., a company acquiring healthcare network assets; and Goodwell Technologies, Inc., a provider of real time-communication and collaboration services in the financial, travel and lodging, healthcare, and other industries. Dr. Keltner holds a master's degree in epidemiology and biostatistics, a Ph.D. degree in biomedical Informatics, and a medical degree from Case Western Reserve University. | 